2020 ASCO Virtual Direct™ Highlights


 

HER2+ EBC Clinical Data: Which Patients Should Be Considered for Neoadjuvant Systemic Therapy? How Should You Handle Residual Disease Post-NAC?

436 views
January 20, 2021
Comments 0
Login to view comments. Click here to Login